与其他抗高血压药物相比,泰尔米萨坦的抗炎潜力:随机试验的二次结果
Simi Bridjit Gomaz1, Jaykaran Charan1, Amal Mohandas2
1Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 342005, Rajasthan, India.
Inflammopharmacology
|October 5, 2025
概括
与其他抗高血压药物相比,泰尔米萨坦在12周内在2型糖尿病和高血压患者中显示出较大减少hsCRP,IL-6和TNF-α等炎症标志物的趋势.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性低度炎症是2型糖尿病 (T2DM) 和高血压的关键因素,增加心血管风险.
- 泰尔米沙坦是一种血管激素受体阻断剂,具有部分PPAR-γ激动剂活性,并可能与血压一起降低炎症.
研究的目的:
- 为了比较telmisartan与标准抗高血压药物的抗炎作用.
- 评估T2DM和高血压患者高灵敏性C反应蛋白 (hsCRP),IL-6 (IL-6) 和瘤亡因子-α (TNF-α) 的变化.
主要方法:
- 一个随机的,开放的,平行组试验,涉及70名T2DM患者和新诊断的高血压.
- 患者接受了telmisartan或其他抗高血压药物 (阿姆洛迪平,西利尼迪平或拉米普利尔).
- 在基线和12周测量了炎症生物标志物 (hsCRP,IL-6,TNF-α).
主要成果:
- 泰尔米沙坦和对照组在12周后都显示hsCRP,IL-6和TNF-α水平降低.
- 在telmisartan和对照组之间没有观察到炎症标志物变化的统计学上显著差异.
- 泰尔米沙坦表明,hsCRP,IL-6和TNF-α的减少趋势更大.
结论:
- 虽然telmisartan在统计学上并不显著,但与其他抗高血压药物相比,它显示出更强的抗炎作用的潜在趋势.
- 需要进一步的大规模试验来确认telmisartan在T2DM和高血压患者的抗炎功效.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
921
09:21Investigation of Xenobiotics Metabolism In Salix alba Leaves via Mass Spectrometry Imaging
Published on: June 15, 2020
3.5K
相关概念视频
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
440
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
440
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
467
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
467